About
BRILL Neurotech (San Francisco, founded 2025) is developing a scalable, non-invasive wearable brain-imaging platform based on Fast Optical Signals (FOS), using AI to map the location and timing of neural firing in real time with millisecond and millimetre precision, positioned between EEG and invasive brain-computer interfaces.
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- BRILL Neurotech
BRILL Neurotech (San Francisco, founded 2025) is developing a scalable, non-invasive wearable brain-imaging platform based on Fast Optical Signals (FOS), using AI to map the location and timing of neural firing in real time with millisecond and millimetre precision, positioned between EEG and invasive brain-computer interfaces.
—
United States
BusinessLatest roundTotal raisedDate- Subsense
Nanoparticle-based non-surgical BCI for implant-free recording and modulation of neural activity
Seed · $10M · 2025-12
$10M - Coherence Neuro
Closed-loop brain-computer interface system SOMA, using a wireless implant to decode tumor electrical signals in real time and deliver personalized electrical stimulation to treat brain tumors and other cancers
Series A · 2026-10
— - Blackrock Neurotech
Develops brain-computer interface technology designed to help patients with paralysis or other neurological conditions control digital devices and regain mobility
Undisclosed · $200M · 2024-05
$200M
China
BusinessLatest roundTotal raisedDate- NeuroXess
Implantable flexible brain-computer interface systems (neural signal acquisition chips + decoding algorithms) for patients with neurological disorders
Series B · 2026-10
— - SiClink
Implantable brain-computer interfaces: in-house flexible neural electrodes and minimally invasive implantation with neural decoding/encoding algorithms, starting with visual restoration for visual impairment rehabilitation
— - BCI-Sonics
Non-invasive AI ultrasound brain-computer interface (transcranial focused ultrasound neuromodulation + multimodal brain reading and AI neural decoding)
Series A · $42M · 2026-09
$42M
Europe
BusinessLatest roundTotal raisedDate- Neurosoft Bioelectronics
Flexible, stretchable, non-penetrating brain-computer interfaces and neural electrodes to record/stimulate brain-surface activity
Seed · $20M · 2026-05
$20M - MintNeuro
Imperial College London spinout developing composable chip modules for neural signal acquisition, electrical stimulation, on-chip processing and wireless transmission, for BCI and active implant makers
Undisclosed · 2026-10
— - InBrain Neuroelectronics
Graphene-based brain-computer interface technology for neurological disorders such as Parkinson's disease.
Series B · $50M · 2024-11
$50M
Other / unspecified
BusinessLatest roundTotal raisedDate- 脑思科技
Brain-computer interface electrodes and neural decoding systems
Angel · $10M · 2026-05
$10M - Brain.space
Non-invasive brain monitoring platform with real-time neural data analysis
Series A · $11M · 2025-03
$11M - Hemispheric
AI analysis of non-invasive brain activity data to aid psychiatric diagnosis
2026-07
—
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Andreessen Horowitz
25 Life Sciences deals in the last 24 months · 23 in Silicon Valley
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.